Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED
This study has been completed.
Study NCT00492635   Information provided by Bayer

First Received on June 26, 2007.   Last Updated on May 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Erectile Dysfunction
Sexual Dysfunction, Physiological
Additional conditions recognized in this trial
Sexual Dysfunctions, Psychological
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Mental Disorders
Sexual and Gender Disorders
Interventions listed in this trial
Levitra (Vardenafil, BAY38-9456)
Placebo
Additional drug interventions recognized in this trial
Vardenafil
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services